Fosun Pharmaceutical (02196): Wu Yifang resigns as non-executive director Zhou Xudong resigns as senior vice president

Zhitongcaijing · 09/30/2025 10:41

Zhitong Finance App News, Fosun Pharmaceutical (02196) issued an announcement. On September 30, 2025, the board of directors of the company received written resignation letters from Mr. Wu Yifang and Mr. Zhou Xudong respectively. The details are as follows: 1. Due to changes in personal work, Mr. Wu Yifang applied to the board of directors to resign as a non-executive director. According to the “Articles of Association of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.” (hereinafter referred to as the “Articles of Association”), Mr. Wu Yifang's resignation took effect when it was served on the board of directors.

2. Due to personal development reasons, Mr. Zhou Xudong applied to the board of directors to resign as senior vice president. Mr. Zhou Xudong will no longer serve as senior vice president of the Company since September 30, 2025.